Per Article 14.2 of Council Directive 93/42/EEC as amended by Directive 2007/47/EC, manufacturers, without a registered place of business in the EU, require to designate a single Authorized European Representative (EAR). AUREPS offers to serve as EAR and as of this assists you in meeting your compliance with conformity assessment procedures, serve as primary contact for EU Authorities and support you in incident reporting.
A manufacturer placing devices on the European market can only do that if that firm is based in the EU, or by using an Authorized Representative (EAR). If the UK leaves the EU, British manufacturers will need an EU-based AR, just like other non-European manufacturers. In other words, the UK will be a “third country.”
We can only speculate on what the UK requirements will be for non-UK based manufacturers and distributors placing devices on the UK market, and for UK-based manufacturers and distributors placing devices on the EU market. We will focus on the impact of Brexit regarding medical devices and IVDs, but the consequences of Brexit will impact all products covered by any EU regulation or directive listed in the annex of the aforementioned notice.